BioSig to Host Telebriefing on Development Updates Regarding Vicromax(tm), a Novel Broad-Spectrum Anti-Viral Candidate That May Treat COVID-19
Stock Information for BioSig Technologies Inc.
Loading
Please wait while we load your information from QuoteMedia.